Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
24 week open-labeled extension study to continue monitoring the same group of patients in the
previous MRA230TW phase IIIb trial in order to evaluate the long term efficacy and safety of
tocilizumab.